cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Taro Pharmaceutical Industries Ltd
3 own
8 watching
Current Price
$42.44
$-0.25
(-0.59%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,473.04M
52-Week High
52-Week High
45.76000
52-Week Low
52-Week Low
32.67000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
11.4465
iconMarket Capitalization1,473.04M
icon52-Week High45.76000
icon52-Week Low32.67000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio11.4465
What does the Taro Pharmaceutical Industries Ltd do?
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Sun Pharmaceutical Industries Ltd.
Read More
News & Events about Taro Pharmaceutical Industries Ltd.
Business Wire
11 months ago
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023, filed with the Securities and Exchange Commission (the...
Ticker Report
1 year ago
Taro Pharmaceutical Industries (NYSE:TARO Get Rating) was downgraded by investment analysts at StockNews.com from a buy rating to a hold rating in a report released on Wednesday. Separately, HC Wainwright decreased their price objective on shares of Taro ...
Zolmax
1 year ago
StockNews.com downgraded shares of Taro Pharmaceutical Industries (NYSE:TARO Get Rating) from a buy rating to a hold rating in a research note issued to investors on Wednesday. Separately, HC Wainwright cut their price target on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy ...
Business Wire
1 year ago
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2022, after the close of market on Thursday, October 27, 2022. The release will be accessible on Taros website at www.taro.com. About Taro Taro...
Frequently Asked Questions
Frequently Asked Questions
What is Taro Pharmaceutical Industries Ltd share price today?
plus_minus_icon
Can Indians buy Taro Pharmaceutical Industries Ltd shares?
plus_minus_icon
How can I buy Taro Pharmaceutical Industries Ltd shares from India?
plus_minus_icon
Can Fractional shares of Taro Pharmaceutical Industries Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Taro Pharmaceutical Industries Ltd stocks?
plus_minus_icon
What is today’s traded volume of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What is today’s market capitalisation of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Taro Pharmaceutical Industries Ltd?
plus_minus_icon
What percentage is Taro Pharmaceutical Industries Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Taro Pharmaceutical Industries Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$42.44
$-0.25
(-0.59%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00